2 completed, 2 terminated, 1 not yet recruiting. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 2, Terminated 2, Not yet recruiting 1 |
Follow Interferons: new trials by email Literature Review of Interferons trials Research Report on Interferons
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antiviral Therapy in Infants With HBV Infection Lamivudine, Interferon - HBV | Phase 4 | Not yet recruiting | Beijing 302 Hospital | 60 | 2024-08-01 | 2024-07-23 |
| A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab Ofatumumab, mRNA COVID-19 vaccine, interferon or glatiramer acetate - Relapsing Multiple Sclerosis (RMS) | Phase 4 | Terminated | Novartis Pharmaceuticals | 24 | 2021-06-10 | 2025-05-16 |
| Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib Nexavar (Sorafenib, BAY43-9006) with addition of gemcitabine or interferon, Gemcitabine or Interferon (only) - Carcinoma, Renal Cell | Phase 4 | Terminated | Bayer | 2 | 2006-08-01 | 2014-12-30 |
| Short Course of Interferon Treatment in Patients With HCV Infection 16 weeks Interferon Tiw with Ribavirin, 24 weeks Interferon - Hepatitis C, Chronic Disease | Phase 4 | Completed | Aga Khan University | 150 | 2004-05-01 | 2008-01-11 |
| Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia Glivec, Interferon - Chronic Myeloid Leukaemia | Phase 4 | Completed | PETHEMA Foundation | 360 | 2003-07-01 | 2008-11-27 |
COVID-19 (1) · Carcinoma, Renal Cell (1) · Chronic Disease (1) · Coronavirus Infections (1) · Hepatitis C (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Multiple Sclerosis (1) · Neoplasms (1)
Aga Khan University (1) · Bayer (1) · Beijing 302 Hospital (1) · Novartis Pharmaceuticals (1) · PETHEMA Foundation (1)
United States (2) · China (1) · Pakistan (1) · Spain (1)
Cervantes Francisco, Dr (1) · Junliang Fu (1) · Saeed S Hamid, FRCP (1)